rs28754326

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.936+46G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.113 in 1,613,546 control chromosomes in the GnomAD database, including 11,511 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2022 hom., cov: 33)
Exomes 𝑓: 0.11 ( 9489 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.656

Publications

5 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 7-94409654-G-A is Benign according to our data. Variant chr7-94409654-G-A is described in ClinVar as Benign. ClinVar VariationId is 674979.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.255 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.936+46G>A intron_variant Intron 18 of 51 ENST00000297268.11 NP_000080.2 P08123A0A0S2Z3H5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.936+46G>A intron_variant Intron 18 of 51 1 NM_000089.4 ENSP00000297268.6 P08123

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22328
AN:
152048
Hom.:
2015
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.259
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.0426
Gnomad SAS
AF:
0.0292
Gnomad FIN
AF:
0.0776
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.143
GnomAD2 exomes
AF:
0.101
AC:
25408
AN:
251450
AF XY:
0.0967
show subpopulations
Gnomad AFR exome
AF:
0.262
Gnomad AMR exome
AF:
0.0807
Gnomad ASJ exome
AF:
0.131
Gnomad EAS exome
AF:
0.0362
Gnomad FIN exome
AF:
0.0803
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.116
GnomAD4 exome
AF:
0.109
AC:
159563
AN:
1461380
Hom.:
9489
Cov.:
41
AF XY:
0.106
AC XY:
77412
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.260
AC:
8689
AN:
33476
American (AMR)
AF:
0.0859
AC:
3843
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
3360
AN:
26136
East Asian (EAS)
AF:
0.0783
AC:
3109
AN:
39698
South Asian (SAS)
AF:
0.0321
AC:
2771
AN:
86252
European-Finnish (FIN)
AF:
0.0832
AC:
4446
AN:
53418
Middle Eastern (MID)
AF:
0.155
AC:
893
AN:
5766
European-Non Finnish (NFE)
AF:
0.113
AC:
125588
AN:
1111526
Other (OTH)
AF:
0.114
AC:
6864
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
8127
16254
24382
32509
40636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4490
8980
13470
17960
22450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.147
AC:
22358
AN:
152166
Hom.:
2022
Cov.:
33
AF XY:
0.141
AC XY:
10520
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.259
AC:
10739
AN:
41472
American (AMR)
AF:
0.115
AC:
1757
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
484
AN:
3470
East Asian (EAS)
AF:
0.0427
AC:
221
AN:
5170
South Asian (SAS)
AF:
0.0299
AC:
144
AN:
4820
European-Finnish (FIN)
AF:
0.0776
AC:
823
AN:
10606
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.114
AC:
7748
AN:
68022
Other (OTH)
AF:
0.142
AC:
300
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
972
1943
2915
3886
4858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.131
Hom.:
2281
Bravo
AF:
0.157
Asia WGS
AF:
0.0520
AC:
181
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.2
DANN
Benign
0.58
PhyloP100
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28754326; hg19: chr7-94038966; API